{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220930",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72213",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214801Orig1s000Correctedltr.pdf",
              "date": "20221006",
              "type": "Letter"
            },
            {
              "id": "72256",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214801Orig1s000lbledt.pdf",
              "date": "20221005",
              "type": "Label"
            },
            {
              "id": "72579",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/214801Orig1s000TOC.html",
              "date": "20221108",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20251015",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "83790",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214801Orig1s005ltr.pdf",
              "date": "20251016",
              "type": "Letter"
            },
            {
              "id": "83795",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214801s005lbl.pdf",
              "date": "20251016",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20240417",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "78156",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214801Orig1s002ltr.pdf",
              "date": "20240418",
              "type": "Letter"
            },
            {
              "id": "78160",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214801s002lbl.pdf",
              "date": "20240419",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA214801",
      "sponsor_name": "TAIHO ONCOLOGY",
      "openfda": {
        "application_number": [
          "NDA214801"
        ],
        "brand_name": [
          "LYTGOBI"
        ],
        "generic_name": [
          "FUTIBATINIB",
          "LYTGOBI"
        ],
        "manufacturer_name": [
          "TAIHO PHARMACEUTICAL CO., LTD."
        ],
        "product_ndc": [
          "64842-0120",
          "64842-0127",
          "64842-0128"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "FUTIBATINIB"
        ],
        "rxcui": [
          "2628195",
          "2628201",
          "2628203",
          "2628204",
          "2628205",
          "2628206",
          "2628207",
          "2628208",
          "2721464",
          "2721466",
          "2721467",
          "2721468",
          "2721469",
          "2721470"
        ],
        "spl_id": [
          "87b2e0c4-3351-4a85-b721-19a0574daafa"
        ],
        "spl_set_id": [
          "0b1332a1-0581-4707-9bf6-1eccfa39bef4"
        ],
        "package_ndc": [
          "64842-0120-6",
          "64842-0120-5",
          "64842-0120-4",
          "64842-0127-7",
          "64842-0128-8"
        ],
        "nui": [
          "N0000175605",
          "N0000194026",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Fibroblast Growth Factor Receptor Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "4B93MGE4AL"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "LYTGOBI",
          "active_ingredients": [
            {
              "name": "FUTIBATINIB",
              "strength": "16MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "LYTGOBI",
          "active_ingredients": [
            {
              "name": "FUTIBATINIB",
              "strength": "4MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}